EMEA-002582-PIP01-19-M03
EMEA-002582-PIP01-19-M03
EMEA-002582-PIP01-19-M03
Orphan designation: Curcumin E100, Resveratrol Treatment of Dercum disease, 11/11/2024 Positive
List of European Union reference dates (EURD) and frequency of submission of periodic safety update reports (PSURs)
Orphan designation: 4-[[(4-Methoxyphenyl)thio]methyl]-N,N-dimethyl-1H-1,2,3-triazole-1-ethanamine Treatment of non-syndromic inherited retinal dystrophies with a rod-dominant phenotype, 11/11/2024 Positive
Orphan designation: 3-chloro-4-fluorophenyl-(4-fluoro-4-(((5-methylpyrimidin-2-ylmethyl)amino)methyl)piperidin-1yl)methanone Treatment of fragile X syndrome, 11/11/2024 Positive
List of industry subject matter experts and list of planned calls for industry subject matter experts
Veterinary Scientific Advice procedure - submission deadlines 2025
EMEA-001855-PIP01-15-M05
Opinion/decision on a Paediatric investigation plan (PIP): Kyprolis, carfilzomib, decision type: PM: decision on the application for modification of an agreed PIP, therapeutic area: Haematology-Hemostaseology;Oncology, PIP number: P/0408/2023
EMEA-002243-PIP01-17-M04